{
  "DOI": "10.1038/s41431-021-00952-4",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-021-00952-4",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eCascade genetic testing is the identification of individuals at risk for a hereditary condition by genetic testing in relatives of people known to possess particular genetic variants. Cascade testing has health system implications, however cascade costs and health effects are not considered in health technology assessments (HTAs) that focus on costs and health consequences in individual patients. Cascade health service use must be better understood to be incorporated in HTA of emerging genetic tests for children. The purpose of this review was to characterise published research related to patterns and costs of cascade health service use by relatives of children with any condition diagnosed through genetic testing. To this end, a scoping literature review was conducted. Citation databases were searched for English-language papers reporting uptake, costs, downstream health service use, or cost-effectiveness of cascade investigations of relatives of children who receive a genetic diagnosis. Included publications were critically appraised, and findings were synthesised. Twenty publications were included. Sixteen had a paediatric proband population; four had a combined paediatric and adult proband population. Uptake of cascade testing varied across diseases, from 37% for cystic fibrosis, 39% to 65% for hypertrophic cardiomyopathy, and 90% for rare monogenic conditions. Two studies evaluated costs. It was concluded that cascade testing in the child-to-parent direction has been reported in a variety of diseases, and that understanding the scope of cascade testing will aid in the design and conduct of HTA of emerging genetic technologies to better inform funding and policy decisions.\u003c/jats:p\u003e",
  "alternative-id": [
    "952"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "23 October 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "6 July 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "12 August 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "26 August 2021"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Institutional research ethics board approval was not required as no human or animal data were collected or analyzed."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-6007-7825",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Cernat",
      "given": "Alexandra",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-3269-8004",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Hayeems",
      "given": "Robin Z.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-0762-0101",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Ungar",
      "given": "Wendy J.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        8,
        26
      ]
    ],
    "date-time": "2021-08-26T07:03:00Z",
    "timestamp": 1629961380000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        11,
        2
      ]
    ],
    "date-time": "2021-11-02T00:05:07Z",
    "timestamp": 1635811507000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        27
      ]
    ],
    "date-time": "2024-03-27T01:34:50Z",
    "timestamp": 1711503290487
  },
  "is-referenced-by-count": 6,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "11",
  "issued": {
    "date-parts": [
      [
        2021,
        8,
        26
      ]
    ]
  },
  "journal-issue": {
    "issue": "11",
    "published-print": {
      "date-parts": [
        [
          2021,
          11
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            8,
            26
          ]
        ],
        "date-time": "2021-08-26T00:00:00Z",
        "timestamp": 1629936000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            8,
            26
          ]
        ],
        "date-time": "2021-08-26T00:00:00Z",
        "timestamp": 1629936000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-021-00952-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00952-4",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00952-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1601-1610",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2021,
        8,
        26
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        8,
        26
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        11
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "952_CR1",
      "unstructured": "National Cancer Institute. NCI dictionary of genetics terms—cascade screening: National Institutes of Health. https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/cascade-screening."
    },
    {
      "key": "952_CR2",
      "unstructured": "Hospital for Sick Children. Pediatric dilated cardiomyopathy guidelines. Hospital for Sick Children; 2016."
    },
    {
      "DOI": "10.1016/j.jval.2017.12.007",
      "author": "DN Lakdawalla",
      "doi-asserted-by": "publisher",
      "first-page": "131",
      "journal-title": "Value Health",
      "key": "952_CR3",
      "unstructured": "Lakdawalla DN, Doshi JA, Garrison LP Jr., Phelps CE, Basu A, Danzon PM. Defining elements of value in health care—a health economics approach: an ISPOR Special Task Force report [3]. Value Health. 2018;21:131–9.",
      "volume": "21",
      "year": "2018"
    },
    {
      "DOI": "10.1001/jama.2016.12195",
      "author": "GD Sanders",
      "doi-asserted-by": "publisher",
      "first-page": "1093",
      "journal-title": "JAMA.",
      "key": "952_CR4",
      "unstructured": "Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316:1093–103.",
      "volume": "316",
      "year": "2016"
    },
    {
      "key": "952_CR5",
      "unstructured": "CADTH. Guidelines for the economic evaluation of health technologies: Canada. Ottawa: CADTH; 2017."
    },
    {
      "DOI": "10.1038/s41436-019-0582-2",
      "author": "M Catchpool",
      "doi-asserted-by": "publisher",
      "first-page": "2815",
      "journal-title": "Genet Med",
      "key": "952_CR6",
      "unstructured": "Catchpool M, Ramchand J, Martyn M, Hare DL, James PA, Trainer AH, et al. A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy. Genet Med. 2019;21:2815–22.",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10897-017-0129-0",
      "author": "S Christian",
      "doi-asserted-by": "publisher",
      "first-page": "124",
      "journal-title": "J Genet Couns",
      "key": "952_CR7",
      "unstructured": "Christian S, Atallah J, Clegg R, Giuffre M, Huculak C, Dzwiniel T, et al. Uptake of predictive genetic testing and cardiac evaluation for children at risk for an inherited arrhythmia or cardiomyopathy. J Genet Couns. 2018;27:124–30.",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1093/eurheartj/ehq067",
      "author": "S Wordsworth",
      "doi-asserted-by": "publisher",
      "first-page": "926",
      "journal-title": "Eur Heart J",
      "key": "952_CR8",
      "unstructured": "Wordsworth S, Leal J, Blair E, Legood R, Thomson K, Seller A, et al. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. Eur Heart J. 2010;31:926–35.",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1186/s12874-018-0611-x",
      "author": "Z Munn",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Med Res Methodol",
      "key": "952_CR9",
      "unstructured": "Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:143.",
      "volume": "18",
      "year": "2018"
    },
    {
      "key": "952_CR10",
      "unstructured": "Mays N, Roberts E, Popay J. Synthesising research evidence. In: Fulop N, Allen P, Clarke A, Black N, editors. Studying the organisation and delivery of health services: research methods. London: Routledge; 2001. p. 188–219."
    },
    {
      "DOI": "10.1371/journal.pmed.1000097",
      "author": "D Moher",
      "doi-asserted-by": "publisher",
      "first-page": "e1000097",
      "journal-title": "PLoS Med",
      "key": "952_CR11",
      "unstructured": "Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.",
      "volume": "6",
      "year": "2009"
    },
    {
      "key": "952_CR12",
      "unstructured": "Scottish Intercollegiate Guidelines Network (SIGN). Critical appraisal notes and checklists [Internet]. 2020. https://www.sign.ac.uk/checklists-and-notes."
    },
    {
      "DOI": "10.4103/0970-0218.58399",
      "author": "AC Gorakshakar",
      "doi-asserted-by": "publisher",
      "first-page": "354",
      "journal-title": "Indian J Community Med",
      "key": "952_CR13",
      "unstructured": "Gorakshakar AC, Colah RB. Cascade screening for beta-thalassemia: a practical approach for identifying and counseling carriers in India. Indian J Community Med. 2009;34:354–6.",
      "volume": "34",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ejhg.2010.78",
      "author": "BJ McClaren",
      "doi-asserted-by": "publisher",
      "first-page": "1084",
      "journal-title": "Eur J Hum Genet",
      "key": "952_CR14",
      "unstructured": "McClaren BJ, Metcalfe SA, Aitken M, Massie RJ, Ukoumunne OC, Amor DJ. Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening. Eur J Hum Genet. 2010;18:1084–9.",
      "volume": "18",
      "year": "2010"
    },
    {
      "DOI": "10.1002/clc.22809",
      "author": "X Wu",
      "doi-asserted-by": "publisher",
      "first-page": "1169",
      "journal-title": "Clin Cardiol",
      "key": "952_CR15",
      "unstructured": "Wu X, Pang J, Wang X, Peng J, Chen Y, Wang S, et al. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families. Clin Cardiol. 2017;40:1169–73.",
      "volume": "40",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.hrthm.2019.06.015",
      "author": "LM Knight",
      "doi-asserted-by": "publisher",
      "first-page": "106",
      "journal-title": "Heart Rhythm",
      "key": "952_CR16",
      "unstructured": "Knight LM, Miller E, Kovach J, Arscott P, von Alvensleben JC, Bradley D, et al. Genetic testing and cascade screening in pediatric long QT syndrome and hypertrophic cardiomyopathy. Heart Rhythm. 2020;17:106–12.",
      "volume": "17",
      "year": "2020"
    },
    {
      "DOI": "10.1038/gim.2012.175",
      "author": "BJ McClaren",
      "doi-asserted-by": "publisher",
      "first-page": "533",
      "journal-title": "Genet Med",
      "key": "952_CR17",
      "unstructured": "McClaren BJ, Aitken M, Massie J, Amor D, Ukoumunne OC, Metcalfe SA. Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing. Genet Med. 2013;15:533–40.",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1038/gim.2014.205",
      "author": "AA Alfares",
      "doi-asserted-by": "publisher",
      "first-page": "880",
      "journal-title": "Genet Med",
      "key": "952_CR18",
      "unstructured": "Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, et al. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015;17:880–8.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41436-018-0006-8",
      "author": "Z Stark",
      "doi-asserted-by": "publisher",
      "first-page": "173",
      "journal-title": "Genet Med",
      "key": "952_CR19",
      "unstructured": "Stark Z, Schofield D, Martyn M, Rynehart L, Shrestha R, Alam K, et al. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness. Genet Med. 2019;21:173–80.",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1056/NEJMoa1602777",
      "author": "DS Wald",
      "doi-asserted-by": "publisher",
      "first-page": "1628",
      "journal-title": "N Engl J Med",
      "key": "952_CR20",
      "unstructured": "Wald DS, Bestwick JP, Morris JK, Whyte K, Jenkins L, Wald NJ. Child-parent familial hypercholesterolemia screening in primary care. N Engl J Med. 2016;375:1628–37.",
      "volume": "375",
      "year": "2016"
    },
    {
      "DOI": "10.5582/irdr.2015.01031",
      "author": "J Famula",
      "doi-asserted-by": "publisher",
      "first-page": "198",
      "journal-title": "Intractable Rare Dis Res",
      "key": "952_CR21",
      "unstructured": "Famula J, Basuta K, Gane LW, Hagerman RJ, Tassone F. Identification of a male with fragile X syndrome through newborn screening. Intractable Rare Dis Res. 2015;4:198–202.",
      "volume": "4",
      "year": "2015"
    },
    {
      "DOI": "10.1002/ajmg.a.35293",
      "author": "PL Sorensen",
      "doi-asserted-by": "publisher",
      "first-page": "1221",
      "journal-title": "Am J Med Genet A",
      "key": "952_CR22",
      "unstructured": "Sorensen PL, Basuta K, Mendoza-Morales G, Gane LW, Schneider A, Hagerman R, et al. A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male. Am J Med Genet A. 2012;158A:1221–4.",
      "volume": "158A",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ajmg.a.35680",
      "author": "PL Sorensen",
      "doi-asserted-by": "publisher",
      "first-page": "59",
      "journal-title": "Am J Med Genet A",
      "key": "952_CR23",
      "unstructured": "Sorensen PL, Gane LW, Yarborough M, Hagerman RJ, Tassone F. Newborn screening and cascade testing for FMR1 mutations. Am J Med Genet A. 2013;161A:59–69.",
      "volume": "161A",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10897-012-9544-4",
      "author": "EM Miller",
      "doi-asserted-by": "publisher",
      "first-page": "258",
      "journal-title": "J Genet Couns",
      "key": "952_CR24",
      "unstructured": "Miller EM, Wang Y, Ware SM. Uptake of cardiac screening and genetic testing among hypertrophic and dilated cardiomyopathy families. J Genet Couns. 2013;22:258–67.",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1055/s-2004-822989",
      "author": "TP Leren",
      "doi-asserted-by": "publisher",
      "first-page": "75",
      "journal-title": "Semin Vasc Med",
      "key": "952_CR25",
      "unstructured": "Leren TP, Manshaus T, Skovholt U, Skodje T, Nossen IE, Teie C, et al. Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program. Semin Vasc Med. 2004;4:75–85.",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.atherosclerosis.2018.06.013",
      "author": "TH Truong",
      "doi-asserted-by": "publisher",
      "first-page": "392",
      "journal-title": "Atherosclerosis.",
      "key": "952_CR26",
      "unstructured": "Truong TH, Kim NT, Nguyen MNT, Pang J, Hooper AJ, Watts GF, et al. Homozygous familial hypercholesterolaemia in Vietnam: case series, genetics and cascade testing of families. Atherosclerosis. 2018;277:392–8.",
      "volume": "277",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "952_CR27",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1136/jmg.2004.027284",
      "author": "E Cadet",
      "doi-asserted-by": "publisher",
      "first-page": "390",
      "journal-title": "J Med Genet",
      "key": "952_CR28",
      "unstructured": "Cadet E, Capron D, Gallet M, Omanga-Leke ML, Boutignon H, Julier C, et al. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases? J Med Genet. 2005;42:390–5.",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1038/hgv.2015.17",
      "author": "S Tairaku",
      "doi-asserted-by": "publisher",
      "first-page": "15017",
      "journal-title": "Hum Genome Var",
      "key": "952_CR29",
      "unstructured": "Tairaku S, Taniguchi-Ikeda M, Okazaki Y, Noguchi Y, Nakamachi Y, Mori T, et al. Prenatal genetic testing for familial severe congenital protein C deficiency. Hum Genome Var. 2015;2:15017.",
      "volume": "2",
      "year": "2015"
    },
    {
      "author": "SM Baig",
      "first-page": "68",
      "journal-title": "Community Genet",
      "key": "952_CR30",
      "unstructured": "Baig SM, Din MA, Hassan H, Azhar A, Baig JM, Aslam M, et al. Prevention of beta-thalassemia in a large Pakistani family through cascade testing. Community Genet. 2008;11:68–70.",
      "volume": "11",
      "year": "2008"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201821",
      "author": "M Smith",
      "doi-asserted-by": "publisher",
      "first-page": "759",
      "journal-title": "Eur J Hum Genet",
      "key": "952_CR31",
      "unstructured": "Smith M, Calabro V, Chong B, Gardiner N, Cowie S, du Sart D. Population screening and cascade testing for carriers of SMA. Eur J Hum Genet. 2007;15:759–66.",
      "volume": "15",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1346-8138.2011.01425.x",
      "author": "S Moriwaki",
      "doi-asserted-by": "publisher",
      "first-page": "516",
      "journal-title": "J Dermatol",
      "key": "952_CR32",
      "unstructured": "Moriwaki S, Yamashita Y, Nakamura S, Fujita D, Kohyama J, Takigawa M, et al. Prenatal diagnosis of xeroderma pigmentosum group A in Japan. J Dermatol. 2012;39:516–9.",
      "volume": "39",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s004170000234",
      "author": "G Rudolph",
      "doi-asserted-by": "publisher",
      "first-page": "167",
      "journal-title": "Graefes Arch Clin Exp Ophthalmol",
      "key": "952_CR33",
      "unstructured": "Rudolph G, Meindl A, Bechmann M, Schworm HD, Achatz H, Boergen KP, et al. X-linked ocular albinism (Nettleship-Falls): a novel 29-bp deletion in exon 1. Carrier detection by ophthalmic examination and DNA analysis. Graefes Arch Clin Exp Ophthalmol. 2001;239:167–72.",
      "volume": "239",
      "year": "2001"
    },
    {
      "DOI": "10.1007/s00246-017-1779-2",
      "author": "CD Ellepola",
      "doi-asserted-by": "publisher",
      "first-page": "491",
      "journal-title": "Pediatr Cardiol",
      "key": "952_CR34",
      "unstructured": "Ellepola CD, Knight LM, Fischbach P, Deshpande SR. Genetic testing in pediatric cardiomyopathy. Pediatr Cardiol. 2018;39:491–500.",
      "volume": "39",
      "year": "2018"
    },
    {
      "DOI": "10.1111/cge.13027",
      "author": "M Sabater-Molina",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Clin Genet",
      "key": "952_CR35",
      "unstructured": "Sabater-Molina M, Perez-Sanchez I, Hernandez del Rincon JP, Gimeno JR. Genetics of hypertrophic cardiomyopathy: a review of current state. Clin Genet. 2018;93:3–14.",
      "volume": "93",
      "year": "2018"
    },
    {
      "key": "952_CR36",
      "unstructured": "National Institutes of Health. Hereditary hemochromatosis. 2020. https://ghr.nlm.nih.gov/condition/hereditary-hemochromatosis."
    },
    {
      "author": "I Miko",
      "first-page": "137",
      "journal-title": "Nat Educ",
      "key": "952_CR37",
      "unstructured": "Miko I. Phenotype variability: penetrance and expressivity. Nat Educ. 2008;1:137.",
      "volume": "1",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ejhg.2015.118",
      "author": "SC Sanderson",
      "doi-asserted-by": "publisher",
      "first-page": "14",
      "journal-title": "Eur J Hum Genet",
      "key": "952_CR38",
      "unstructured": "Sanderson SC, Linderman MD, Suckiel SA, Diaz GA, Zinberg RE, Ferryman K, et al. Motivations, concerns and preferences of personal genome sequencing research participants: caseline findings from the HealthSeq project. Eur J Hum Genet. 2016;24:14–20.",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1093/eurheartj/ehu199",
      "author": "PM Elliott",
      "doi-asserted-by": "publisher",
      "first-page": "2733",
      "journal-title": "Eur Heart J",
      "key": "952_CR39",
      "unstructured": "Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.",
      "volume": "35",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.jacc.2020.08.045",
      "author": "SR Ommen",
      "doi-asserted-by": "publisher",
      "first-page": "e159",
      "journal-title": "J Am Coll Cardiol",
      "key": "952_CR40",
      "unstructured": "Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020;76:e159–240.",
      "volume": "76",
      "year": "2020"
    },
    {
      "DOI": "10.1093/eurheartj/ehq067",
      "author": "S Wordsworth",
      "doi-asserted-by": "publisher",
      "first-page": "926",
      "journal-title": "Eur Heart J",
      "key": "952_CR41",
      "unstructured": "Wordsworth S, Leal J, Blair E, Legood R, Thomson K, Seller A, et al. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. Eur Heart J. 2010;31:926–35.",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1136/heartjnl-2011-300368",
      "doi-asserted-by": "crossref",
      "key": "952_CR42",
      "unstructured": "Ingles J, McGaughran J, Scuffham PA, Atherton J, Semsarian C. A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy. Heart. 2012;98:625–30."
    },
    {
      "DOI": "10.1016/j.atherosclerosis.2020.05.007",
      "author": "Z Ademi",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Atherosclerosis.",
      "key": "952_CR43",
      "unstructured": "Ademi Z, Norman R, Pang J, Liew D, Zoungas S, Sijbrands E, et al. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment? Atherosclerosis. 2020;304:1–8.",
      "volume": "304",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.jacl.2014.05.008",
      "author": "Z Ademi",
      "doi-asserted-by": "publisher",
      "first-page": "390",
      "journal-title": "J Clin Lipido",
      "key": "952_CR44",
      "unstructured": "Ademi Z, Watts GF, Pang J, Sijbrands EJ, van Bockxmeer FM, O’Leary P, et al. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia. J Clin Lipido. 2014;8:390–400.",
      "volume": "8",
      "year": "2014"
    },
    {
      "DOI": "10.1093/eurheartj/ehz396",
      "author": "M Lafreniere-Roula",
      "doi-asserted-by": "publisher",
      "first-page": "3672",
      "journal-title": "Eur Heart J",
      "key": "952_CR45",
      "unstructured": "Lafreniere-Roula M, Bolkier Y, Zahavich L, Mathew J, George K, Wilson J, et al. Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines? Eur Heart J. 2019;40:3672–81.",
      "volume": "40",
      "year": "2019"
    }
  ],
  "reference-count": 45,
  "references-count": 45,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-021-00952-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Cascade health service use in family members following genetic testing in children: a scoping literature review"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "29"
}